Symbols / MMED Stock $11.57 -1.36% MiniMed Group, Inc.

Healthcare • Health Information Services • United States • NMS
MMED (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Ms. Que Thanh Dallara
Exch · Country NMS · United States
Market Cap 3.25B
Enterprise Value 3.30B
Income -320.00M
Sales 2.99B
FCF (ttm) —
Book/sh —
Cash/sh 0.04
Employees 8,000
Insider 10d —
IPO Mar 06, 2026
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 17.21
PEG —
P/S 1.09
P/B —
P/C —
EV/EBITDA 14.60
EV/Sales 1.10
Quick Ratio 0.95
Current Ratio 1.59
Debt/Eq 1.76
LT Debt/Eq —
EPS (ttm) -1.27
EPS next Y 0.67
EPS Growth —
Revenue Growth 15.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-06-03
Earnings (prior) 2026-04-17
ROA —
ROE —
ROIC —
Gross Margin 56.74%
Oper. Margin -11.01%
Profit Margin -10.71%
Shs Outstand 280.82M
Shs Float 28.00M
Insider Own 90.51%
Instit Own 2.73%
Short Float 10.20%
Short Ratio 3.20
Short Interest 2.86M
52W High 20.48
vs 52W High -43.51%
52W Low 11.25
vs 52W Low 2.84%
Beta —
Impl. Vol. 3.98%
Rel Volume 0.49
Avg Volume 1.09M
Volume 538.43K
Target (mean) $22.45
Tgt Median $23.00
Tgt Low $16.00
Tgt High $27.00
# Analysts 11
Recom Strong_buy
Prev Close $11.73
Price $11.57
Change -1.36%
About

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera, or Guardian 4, and wraparound applications and services. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$22.45
Mean price target
2. Current target
$11.57
Latest analyst target
3. DCF / Fair value
$22.45
Proxy: analyst mean price target (no FCF/EPS data available).
Ratings
Current target
$11.57
Low
$16.00
High
$27.00
Mean
$22.45

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-01 init Barclays — → Overweight $26
2026-03-31 init William Blair — → Outperform —
2026-03-31 init Citigroup — → Buy $23
2026-03-31 init Piper Sandler — → Neutral $16
2026-03-31 init Mizuho — → Outperform $21
2026-03-31 init Wells Fargo — → Overweight $26
2026-03-31 init Morgan Stanley — → Overweight $19
2026-03-31 init Evercore ISI Group — → Outperform $20
2026-03-31 init B of A Securities — → Buy $27
2026-03-31 init BTIG — → Buy $25
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-04-30 2024-04-30 2023-04-30
Total Revenue
2,715.00
+9.96%
2,469.00
+9.98%
2,245.00
Operating Revenue
2,715.00
+9.96%
2,469.00
+9.98%
2,245.00
Cost Of Revenue
1,190.00
+15.31%
1,032.00
+10.14%
937.00
Reconciled Cost Of Revenue
1,190.00
+15.31%
1,032.00
+10.14%
937.00
Gross Profit
1,525.00
+6.20%
1,436.00
+9.79%
1,308.00
Operating Expense
1,561.00
+3.72%
1,505.00
+9.30%
1,377.00
Research And Development
438.00
+0.23%
437.00
+1.86%
429.00
Selling General And Administration
1,131.00
+7.00%
1,057.00
+10.10%
960.00
Selling And Marketing Expense
1,131.00
+7.00%
1,057.00
+10.10%
960.00
Other Operating Expenses
-8.00
-172.73%
11.00
+191.67%
-12.00
Total Expenses
2,751.00
+8.44%
2,537.00
+9.64%
2,314.00
Operating Income
-36.00
+47.83%
-69.00
+0.00%
-69.00
Total Operating Income As Reported
-202.00
-192.75%
-69.00
+0.00%
-69.00
EBITDA
107.00
+78.33%
60.00
+30.43%
46.00
Normalized EBITDA
272.00
+353.33%
60.00
+30.43%
46.00
Reconciled Depreciation
143.00
+10.85%
129.00
+12.17%
115.00
EBIT
-36.00
+47.83%
-69.00
+0.00%
-69.00
Total Unusual Items
-165.00
0.00
0.00
Total Unusual Items Excluding Goodwill
-165.00
0.00
0.00
Special Income Charges
-165.00
0.00
0.00
Other Special Charges
165.00
—
—
Net Income
-250.00
-123.21%
-112.00
-16.67%
-96.00
Pretax Income
-203.00
-190.00%
-70.00
+7.89%
-76.00
Other Income Expense
-166.00
-16500.00%
-1.00
+85.71%
-7.00
Other Non Operating Income Expenses
-1.00
+0.00%
-1.00
+85.71%
-7.00
Tax Provision
48.00
+26.32%
38.00
+137.50%
16.00
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-34.65
0.00
0.00
Net Income Including Noncontrolling Interests
-250.00
-133.64%
-107.00
-16.30%
-92.00
Net Income From Continuing Operation Net Minority Interest
-250.00
-123.21%
-112.00
-16.67%
-96.00
Net Income From Continuing And Discontinued Operation
-250.00
-123.21%
-112.00
-16.67%
-96.00
Net Income Continuous Operations
-251.00
-132.41%
-108.00
-17.39%
-92.00
Minority Interests
0.00
+100.00%
-5.00
+0.00%
-5.00
Normalized Income
-119.65
-6.83%
-112.00
-16.67%
-96.00
Net Income Common Stockholders
-250.00
-123.21%
-112.00
-16.67%
-96.00
Diluted EPS
-0.89
-123.15%
-0.40
-16.67%
-0.34
Basic EPS
-0.89
-123.15%
-0.40
-16.67%
-0.34
Basic Average Shares
280.81
+0.00%
280.81
+0.00%
280.81
Diluted Average Shares
280.81
+0.00%
280.81
+0.00%
280.81
Diluted NI Availto Com Stockholders
-250.00
-123.21%
-112.00
-16.67%
-96.00
Line Item Trend 2025-04-30 2024-04-30
Total Assets
4,201.00
+2.61%
4,094.00
Current Assets
939.00
+4.92%
895.00
Cash Cash Equivalents And Short Term Investments
11.00
-79.63%
54.00
Cash And Cash Equivalents
11.00
-79.63%
54.00
Receivables
570.00
+12.43%
507.00
Accounts Receivable
570.00
+12.43%
507.00
Gross Accounts Receivable
616.00
+12.61%
547.00
Allowance For Doubtful Accounts Receivable
-46.00
-15.00%
-40.00
Inventory
310.00
+6.16%
292.00
Raw Materials
87.00
-12.12%
99.00
Work In Process
38.00
+35.71%
28.00
Finished Goods
185.00
+12.12%
165.00
Other Current Assets
48.00
+14.29%
42.00
Total Non Current Assets
3,261.00
+1.97%
3,198.00
Net PPE
706.00
+11.01%
636.00
Gross PPE
1,369.00
+14.85%
1,192.00
Accumulated Depreciation
-663.00
-19.24%
-556.00
Properties
0.00
0.00
Land And Improvements
7.00
+0.00%
7.00
Buildings And Improvements
233.00
+8.88%
214.00
Machinery Furniture Equipment
447.00
+33.83%
334.00
Construction In Progress
286.00
-2.72%
294.00
Other Properties
396.00
+15.45%
343.00
Goodwill And Other Intangible Assets
2,386.00
-1.20%
2,415.00
Goodwill
2,255.00
+0.00%
2,255.00
Other Intangible Assets
131.00
-18.13%
160.00
Non Current Accounts Receivable
19.00
+18.75%
16.00
Other Non Current Assets
150.00
+14.50%
131.00
Total Liabilities Net Minority Interest
870.00
+34.67%
646.00
Current Liabilities
710.00
+37.07%
518.00
Payables And Accrued Expenses
505.00
+52.57%
331.00
Payables
205.00
+7.89%
190.00
Accounts Payable
205.00
+7.89%
190.00
Current Accrued Expenses
300.00
+112.77%
141.00
Pensionand Other Post Retirement Benefit Plans Current
182.00
+7.69%
169.00
Current Debt And Capital Lease Obligation
11.00
+37.50%
8.00
Current Capital Lease Obligation
11.00
+37.50%
8.00
Current Deferred Liabilities
11.00
+0.00%
11.00
Current Deferred Revenue
11.00
+0.00%
11.00
Other Current Liabilities
1.00
+200.00%
-1.00
Total Non Current Liabilities Net Minority Interest
160.00
+25.00%
128.00
Other Non Current Liabilities
160.00
+25.00%
128.00
Stockholders Equity
3,331.00
-3.39%
3,448.00
Common Stock Equity
3,331.00
-3.39%
3,448.00
Share Issued
280.81
+0.00%
280.81
Ordinary Shares Number
280.81
+0.00%
280.81
Gains Losses Not Affecting Retained Earnings
3.00
+118.75%
-16.00
Other Equity Adjustments
3.00
+118.75%
-16.00
Total Equity Gross Minority Interest
3,331.00
-3.39%
3,448.00
Total Capitalization
3,331.00
-3.39%
3,448.00
Working Capital
229.00
-39.26%
377.00
Invested Capital
3,331.00
-3.39%
3,448.00
Total Debt
11.00
+37.50%
8.00
Capital Lease Obligations
11.00
+37.50%
8.00
Net Tangible Assets
945.00
-8.52%
1,033.00
Tangible Book Value
945.00
-8.52%
1,033.00
Other Equity Interest
3,328.00
-3.93%
3,464.00
Line Item Trend 2025-04-30 2024-04-30 2023-04-30
Operating Cash Flow
140.00
+241.46%
41.00
+783.33%
-6.00
Cash Flow From Continuing Operating Activities
140.00
+250.00%
40.00
+1100.00%
-4.00
Net Income From Continuing Operations
-198.00
-85.05%
-107.00
-16.30%
-92.00
Depreciation Amortization Depletion
143.00
+10.85%
129.00
+12.17%
115.00
Depreciation
114.00
+18.75%
96.00
+17.07%
82.00
Amortization Cash Flow
29.00
-12.12%
33.00
+0.00%
33.00
Depreciation And Amortization
143.00
+10.85%
129.00
+12.17%
115.00
Amortization Of Intangibles
29.00
-12.12%
33.00
+0.00%
33.00
Other Non Cash Items
5.00
-77.27%
22.00
+83.33%
12.00
Pension And Employee Benefit Expense
8.00
+0.00%
8.00
-20.00%
10.00
Stock Based Compensation
41.00
+7.89%
38.00
+8.57%
35.00
Provisionand Write Offof Assets
21.00
-4.55%
22.00
+46.67%
15.00
Deferred Tax
-2.00
-166.67%
3.00
+127.27%
-11.00
Deferred Income Tax
-2.00
-166.67%
3.00
+127.27%
-11.00
Operating Gains Losses
8.00
+0.00%
8.00
-20.00%
10.00
Change In Working Capital
122.00
+264.86%
-74.00
+17.78%
-90.00
Change In Receivables
-66.00
+37.14%
-105.00
-50.00%
-70.00
Changes In Account Receivables
-66.00
+37.14%
-105.00
-50.00%
-70.00
Change In Inventory
-19.00
-480.00%
5.00
+117.86%
-28.00
Change In Payables And Accrued Expense
191.00
+4875.00%
-4.00
-128.57%
14.00
Change In Payable
191.00
+4875.00%
-4.00
-128.57%
14.00
Change In Account Payable
191.00
+4875.00%
-4.00
-128.57%
14.00
Change In Other Working Capital
16.00
-46.67%
30.00
+600.00%
-6.00
Investing Cash Flow
-193.00
-22.93%
-157.00
+12.78%
-180.00
Cash Flow From Continuing Investing Activities
-193.00
-23.72%
-156.00
+13.33%
-180.00
Net PPE Purchase And Sale
-193.00
-30.41%
-148.00
+11.38%
-167.00
Purchase Of PPE
-193.00
-30.41%
-148.00
+11.38%
-167.00
Capital Expenditure
-193.00
-30.41%
-148.00
+11.38%
-167.00
Net Investment Purchase And Sale
0.00
-100.00%
6.00
+146.15%
-13.00
Purchase Of Investment
0.00
+100.00%
-5.00
+61.54%
-13.00
Sale Of Investment
0.00
-100.00%
11.00
0.00
Net Other Investing Changes
—
-15.00
—
Financing Cash Flow
10.00
-91.07%
112.00
-39.46%
185.00
Cash Flow From Continuing Financing Activities
10.00
-91.07%
112.00
-39.46%
185.00
Net Other Financing Charges
10.00
-91.07%
112.00
-39.46%
185.00
Changes In Cash
-43.00
-975.00%
-4.00
-100.00%
-2.00
Beginning Cash Position
54.00
-6.90%
58.00
-3.33%
60.00
End Cash Position
11.00
-79.63%
54.00
-6.90%
58.00
Free Cash Flow
-53.00
+50.47%
-107.00
+38.15%
-173.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category